BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 15130370)

  • 1. [Effect of pelvic lymphadenectomy on prognosis of endometrial carcinoma].
    Wen HW; Zhang LD
    Zhonghua Fu Chan Ke Za Zhi; 2004 Mar; 39(3):152-5. PubMed ID: 15130370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impact of surgical resection extent on the prognosis of clinical stage I endometrial carcinoma].
    Yan X; Gao YN; Jiang GQ; Gao M; An N
    Zhonghua Zhong Liu Za Zhi; 2009 Mar; 31(3):208-12. PubMed ID: 19615262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
    Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
    Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Para-aortic lymphadenectomy improves survival in patients with intermediate to high-risk endometrial carcinoma.
    Chang SJ; Kim WY; Yoon JH; Yoo SC; Chang KH; Ryu HS
    Acta Obstet Gynecol Scand; 2008; 87(12):1361-9. PubMed ID: 18951214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multivariate analysis of prognostic factors in endometrial carcinoma].
    Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK
    Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T; Nanjyo H; Nakamura A; Yokoyama Y; Takano T; Shoji T; Nakahara K; Yamada H; Mizunuma H; Yaegashi N; Sugiyama T; Kurachi H; Sato A; Tanaka T
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
    Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
    Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we omit para-aorta lymph node dissection in endometrial cancer?
    Tanaka H; Sato H; Miura H; Sato N; Fujimoto T; Konishi Y; Takahashi O; Tanaka T
    Jpn J Clin Oncol; 2006 Sep; 36(9):578-81. PubMed ID: 16870694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Place of value of pelvic lymphadenectomy for treatment of endometrial neoplasms].
    Gao Y; Yu A; Chen L
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):264-6. PubMed ID: 11775902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis on the lymph nodes metastasis characters and their relation with the prognosis of the endometrial carcinoma patients].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):435-40. PubMed ID: 21781585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
    Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
    Yokoyama Y; Maruyama H; Sato S; Saito Y
    Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pelvic lymph node metastasis in endometrial carcinoma.
    Kamura T; Yahata H; Shigematsu T; Ogawa S; Amada S; Kaku T; Nakano H
    Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omission of lymphadenectomy is possible for low-risk corpus cancer.
    Hidaka T; Kato K; Yonezawa R; Shima T; Nakashima A; Nagira K; Nakamura T; Saito S
    Eur J Surg Oncol; 2007 Feb; 33(1):86-90. PubMed ID: 17095180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.